Nasdaq · CIK 0001671502
QNRX Quoin Pharmaceuticals, Ltd.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $4.50 on Oct 9, 2026, +38% from the 52-week low and -80% from the high.
Last 90 days
Net insider value
+$280k
more bought than sold
Buys
4
$280k by 4 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
QNRXOct 9, 2026 · close 4.50
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Quoin Pharmaceuticals, Ltd., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Denise P. Carter Chief Operating Officer buy | $100k 20,490 shares | +119% | - | |
| 38Weak | Anthony James Culverwell director buy | $30k 6,146 shares | +18% | - | |
| 54Moderate | Sally Bridget Lawlor Chief Financial Officer buy | $50k 10,244 shares | +2328% | - | |
| 60Notable | Michael Myers Chief Executive Officer buy | $100k 20,490 shares | +119% | - | |
| 44Moderate | Dennis Langer director buy | $129k 15,152 shares | first purchase | +166% from low-54% from high | |
| 58Moderate | Denise P. Carter Chief Operating Officer buy | $250k 555,556 shares | +1180% | - | |
| 46Moderate | Anthony James Culverwell director buy | $45k 100,000 shares | first purchase | - | |
| 54Moderate | Gordon Dunn Chief Financial Officer buy | $55k 122,221 shares | +424% | - | |
| 63Notable | Michael Myers Chief Executive Officer buy | $250k 555,556 shares | +1176% | - |
Transactions
The last 54 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Denise P. Carter Chief Operating Officer | POpen-market purchase ADSs | +20,490 | $4.88 | $100k | 37,709 | 41 d ago |
| Aug 31, 2026 | Anthony James Culverwell director | POpen-market purchase ADSs | +6,146 | $4.88 | $30k | 40,364 | 41 d ago |
| Aug 31, 2026 | Sally Bridget Lawlor Chief Financial Officer | POpen-market purchase ADSs | +10,244 | $4.88 | $50k | 10,684 | 41 d ago |
| Aug 31, 2026 | Michael Myers Chief Executive Officer | POpen-market purchase ADSs | +20,490 | $4.88 | $100k | 37,713 | 41 d ago |
| Aug 31, 2026 | Denise P. Carter Chief Operating Officer | POpen-market purchase Ordinary Warrants (Right to Buy)derivative | +10,245 | - | - | 10,245 | 41 d ago |
| Aug 31, 2026 | Michael Myers Chief Executive Officer | POpen-market purchase Ordinary Warrants (Right to Buy)derivative | +10,245 | - | - | 10,245 | 41 d ago |
| Aug 31, 2026 | Anthony James Culverwell director | POpen-market purchase Ordinary Warrants (Right to Buy)derivative | +3,073 | - | - | 3,073 | 41 d ago |
| Aug 31, 2026 | Sally Bridget Lawlor Chief Financial Officer | POpen-market purchase Ordinary Warrants (Right to Buy)derivative | +5,122 | - | - | 5,122 | 41 d ago |
| Feb 4, 2026 | Denise P. Carter Chief Operating Officer | AGrant or award Share Option (Right to Buy)derivative | +318,750 | $0.00 | $0 | 318,750 | Feb 6, 2026 |
| Feb 4, 2026 | Joseph Patrick Cooper director | AGrant or award Share Option (Right to Buy)derivative | +8,141 | $0.00 | $0 | 8,141 | Feb 6, 2026 |
| Feb 4, 2026 | Anthony James Culverwell director | AGrant or award Share Option (Right to Buy)derivative | +21,709 | $0.00 | $0 | 21,709 | Feb 6, 2026 |
| Feb 4, 2026 | Dennis Langer director | AGrant or award Share Option (Right to Buy)derivative | +21,709 | $0.00 | $0 | 21,709 | Feb 6, 2026 |
| Feb 4, 2026 | Sally Bridget Lawlor Chief Financial Officer | AGrant or award Share Option (Right to Buy)derivative | +85,250 | $0.00 | $0 | 85,250 | Feb 6, 2026 |
| Feb 4, 2026 | Natalie Ee Mun Leong director | AGrant or award Share Option (Right to Buy)derivative | +12,211 | $0.00 | $0 | 12,211 | Feb 6, 2026 |
| Feb 4, 2026 | Michael Myers Chief Executive Officer | AGrant or award Share Option (Right to Buy)derivative | +318,750 | $0.00 | $0 | 318,750 | Feb 6, 2026 |
| Feb 4, 2026 | Michael T Sember director | AGrant or award Share Option (Right to Buy)derivative | +8,141 | $0.00 | $0 | 8,141 | Feb 6, 2026 |
| Dec 1, 2025 | Sally Bridget Lawlor Chief Financial Officer | AGrant or award Share Option (Right to Buy)derivative | +10,330 | $0.00 | $0 | 10,330 | Dec 3, 2025 |
| Oct 14, 2025 | Dennis Langer director | POpen-market purchase ADSs | +15,152 | $8.49 | $129k | 15,153 | Oct 15, 2025 |
| Oct 14, 2025 | Dennis Langer director | POpen-market purchase Series H Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | Dennis Langer director | POpen-market purchase Series I Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | Dennis Langer director | POpen-market purchase Series J Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | Dennis Langer director | POpen-market purchase Series K Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Aug 21, 2025 | Anthony James Culverwell director | AGrant or award Share Option (Right to Buy)derivative | +13,682 | $0.00 | $0 | 13,682 | Aug 25, 2025 |
| Aug 21, 2025 | Dennis Langer director | AGrant or award Share Option (Right to Buy)derivative | +13,682 | $0.00 | $0 | 13,682 | Aug 25, 2025 |
| Aug 21, 2025 | Natalie Ee Mun Leong director | AGrant or award Share Option (Right to Buy)derivative | +4,105 | $0.00 | $0 | 4,105 | Aug 25, 2025 |
| May 29, 2025 | Michael Myers Chief Executive Officer | AGrant or award Share Option (Right to Buy)derivative | +42,857 | $0.00 | $0 | 42,857 | Jun 13, 2025 |
| May 29, 2025 | Denise P. Carter Chief Operating Officer | AGrant or award Share Option (Right to Buy)derivative | +42,857 | $0.00 | $0 | 42,857 | Jun 13, 2025 |
| May 29, 2025 | Anthony James Culverwell director | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 3, 2025 |
| May 29, 2025 | Natalie Ee Mun Leong director | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| May 29, 2025 | Michael Myers Chief Executive Officer | AGrant or award Share Option (Right to Buy)derivative | +42,039 | $0.00 | $0 | 42,039 | Jun 2, 2025 |
| May 29, 2025 | Michael T Sember director | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| May 29, 2025 | Joseph Patrick Cooper director | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| May 29, 2025 | Denise P. Carter Chief Operating Officer | AGrant or award Share Option (Right to Buy)derivative | +42,039 | $0.00 | $0 | 42,039 | Jun 2, 2025 |
| May 29, 2025 | Dennis Langer director | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| Dec 23, 2024 | Denise P. Carter Chief Operating Officer | POpen-market purchase Ordinary Shares | +555,556 | $0.45 | $250k | 602,648 | Dec 27, 2024 |
| Dec 23, 2024 | Michael Myers Chief Executive Officer | POpen-market purchase Ordinary Shares | +555,556 | $0.45 | $250k | 602,808 | Dec 27, 2024 |
| Dec 23, 2024 | Anthony James Culverwell director | POpen-market purchase Ordinary Shares | +100,000 | $0.45 | $45k | 100,317 | Dec 27, 2024 |
| Dec 23, 2024 | Gordon Dunn Chief Financial Officer | POpen-market purchase Ordinary Shares | +122,221 | $0.45 | $55k | 151,077 | Dec 27, 2024 |
| Dec 23, 2024 | Gordon Dunn Chief Financial Officer | POpen-market purchase Series F Warrants (right to buy)derivative | +122,221 | - | - | 122,221 | Dec 27, 2024 |
| Dec 23, 2024 | Michael Myers Chief Executive Officer | POpen-market purchase Series F Warrants (right to buy)derivative | +555,556 | - | - | 555,556 | Dec 27, 2024 |
| Dec 23, 2024 | Anthony James Culverwell director | POpen-market purchase Series F Warrants (right to buy)derivative | +100,000 | - | - | 100,000 | Dec 27, 2024 |
| Dec 23, 2024 | Denise P. Carter Chief Operating Officer | POpen-market purchase Series F Warrants (right to buy)derivative | +555,556 | - | - | 555,556 | Dec 27, 2024 |
| Dec 23, 2024 | Anthony James Culverwell director | POpen-market purchase Series G Warrants (right to buy)derivative | +100,000 | - | - | 100,000 | Dec 27, 2024 |
| Dec 23, 2024 | Gordon Dunn Chief Financial Officer | POpen-market purchase Series G Warrants (right to buy)derivative | +122,221 | - | - | 122,221 | Dec 27, 2024 |
| Dec 23, 2024 | Denise P. Carter Chief Operating Officer | POpen-market purchase Series G Warrants (right to buy)derivative | +555,556 | - | - | 555,556 | Dec 27, 2024 |
| Dec 23, 2024 | Michael Myers Chief Executive Officer | POpen-market purchase Series G Warrants (right to buy)derivative | +555,556 | - | - | 555,556 | Dec 27, 2024 |
| Dec 9, 2024 | Denise P. Carter Chief Operating Officer | AGrant or award Share Option (Right to Buy)derivative | +536,609 | $0.00 | $0 | 536,609 | Dec 10, 2024 |
| Dec 9, 2024 | Joseph Patrick Cooper director | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
| Dec 9, 2024 | Anthony James Culverwell director | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
| Dec 9, 2024 | Gordon Dunn Chief Financial Officer | AGrant or award Share Option (Right to Buy)derivative | +338,994 | $0.00 | $0 | 338,994 | Dec 10, 2024 |
| Dec 9, 2024 | Dennis Langer director | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
| Dec 9, 2024 | Natalie Ee Mun Leong director | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
| Dec 9, 2024 | Michael Myers Chief Executive Officer | AGrant or award Share Option (Right to Buy)derivative | +536,603 | $0.00 | $0 | 536,603 | Dec 10, 2024 |
| Dec 9, 2024 | Michael T Sember director | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Denise P. CarterChief Operating Officer
- Joseph Patrick Cooperdirector
- Anthony James Culverwelldirector
- Gordon DunnChief Financial Officer
- Dennis Langerdirector
- Sally Bridget LawlorChief Financial Officer
- Natalie Ee Mun Leongdirector
- Michael MyersChief Executive Officer
- Michael T Semberdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.